摘要
Rationale & Objective: Nonalbuminuric diabetic kidney disease (DKD) has become the prevailing DKD phenotype. We compared the risks of adverse outcomes among patients with this phenotype compared with other DKD phenotypes.Study Design: Multicenter prospective cohort study.Settings & Participants: 19,025 Chinese adults with type 2 diabetes enrolled in the Hong Kong Diabetes Biobank.Exposures: DKD phenotypes defined by baseline estimated glomerular filtration rate (eGFR) and albuminuria: no DKD (no decreased eGFR or albuminuria), albuminuria without decreased eGFR, decreased eGFR without albuminuria, and albuminuria with decreased eGFR.Outcomes: All-cause mortality, cardiovascular disease (CVD) events, hospitalization for heart failure (HF), and chronic kidney disease (CKD) progression (incident kidney failure or sustained eGFR reduction >= 40%).Analytical Approach: Multivariable Cox propor-tional or cause-specific hazards models to estimate the relative risks of death, CVD, hospitalization for HF, and CKD progression. Multiple imputation was used for missing covariates.Results: Mean participant age was 61.1 years, 58.3% were male, and mean diabetes duration was 11.1 years. During 54,260 person-years of follow-up, 438 deaths, 1,076 CVD events, 298 hospitalizations for HF, and 1,161 episodes of CKD progression occurred. Compared with the no-DKD subgroup, the subgroup with decreased eGFR without albuminuria had higher risks of all-cause mortality (hazard ratio [HR], 1.59 [95% CI, 1.04-2.4 4]), hospitalization for HF (HR, 3.08 [95% CI, 1.82-5.21]), and CKD progression (HR, 2.37 [95% CI, 1.63-3.43]), but the risk of CVD was not significantly greater (HR, 1.14 [95% CI, 0.88-1.4 8]). The risks of death, CVD, hospitalization for HF, and CKD progression were higher in the setting of albuminuria with or without decreased eGFR. A sensitivity analysis that excluded participants with baseline eGFR <30 mL/min/1.73 m2 yielded similar findings.Limitations: Potential misclassification because of drug use.Conclusions: Nonalbuminuric DKD was associ-ated with higher risks of hospitalization for HF and of CKD progression than no DKD, regardless of baseline eGFR.
学科与关键词
- Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rateNiu, Jingya; Zhang, Xiaoyun; Li, Mian; Wu, Shujing; Zheng, Ruizhi; Chen, Li; Huo, Yanan; Xu, Min; Wang, Tiange; Zhao, Zhiyun; Wang, Shuangyuan; Lin, Hong; Qin, Guijun; Yan, Li; Wan, Qin; Chen, Lulu; Shi, Lixin; Hu, Ruying; Tang, Xulei; Su, Qing; Yu, Xuefeng; Qin, Yingfen; Chen, Gang; Gao, Zhengnan; Wang, Guixia; Shen, Feixia; Luo, Zuojie; Chen, Yuhong; Zhang, Yinfei; Liu, Chao; Wang, Youmin; Wu, Shengli; Yang, Tao; Li, Qiang; Mu, Yiming; Zhao, Jiajun; Bi, Yufang; Ning, Guang; Wang, WeiqingDiabetes and Metabolism, 2023, 49(2): 101420.被引 1
- Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialWheeler, David C.*; Stefansson, Bergur, V; Jongs, Niels; Chertow, Glenn M.; Greene, Tom; Hou, Fan Fan; McMurray, John J., V; Correa-Rotter, Ricardo; Rossing, Peter; Toto, Robert D.; Sjostrom, C. David; Langkilde, Anna Maria; Heerspink, Hiddo J. L.Lancet Diabetes & Endocrinology, 2021, 9(1): 22-31.被引 258
- Association of Urinary Sodium Excretion and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional StudyHuang, Yan; Liu, Wenhui; Liu, Jianfang; Guo, Dan; Zhang, Peizhen; Liu, Deying; Lin, Jiayang; Yang, Linjie; Zhang, Huijie*; Xue, Yaoming*Frontiers in Endocrinology, 2021, 12: 772073.被引 4
